Vir, GSK win emergency use OK for Covid-fighting antibody

Little more than a year after Vir Biotechnology Inc. decided to scan its antibody library for potential foes of the coronavirus responsible for the Covid-19 pandemic, the San Francisco company and partner GlaxoSmithKline plc won a Food and Drug Administration emergency use authorization for their drug to treat...

Click to view original post